Upstream Bio is a clinical-stage biotechnology company focused on developing verekitug, a monoclonal antibody targeting the TSLP receptor to treat severe respiratory diseases driven by chronic inflammation
Upstream Bio is a clinical-stage biotechnology company focused on developing verekitug, a monoclonal antibody targeting the TSLP receptor to treat severe respiratory diseases driven by chronic inflammation.